Bevacizumab continuation versus treatment holidays after first-line chemotherapy with bevacizumab in patients with metastatic colorectal cancer: a health economic analysis of a randomised phase III trial (SAKK 41/06)
Panje CM, Putora PM, Hundsberger T, Hottinger AF, Roelcke U, Pesce G, Herrmann E, Matter-Walstra K.
Swiss Med Wkly. 2019 Dec 2;149:w20153. doi: 10.4414/smw.2019.20153. eCollection 2019 Dec 2.